Rho F inhibitors are a class of chemical compounds that specifically target and inhibit the function of Rho F, a member of the Rho family of small GTPases. Rho F, also known as Rif, plays a critical role in regulating the dynamics of the actin cytoskeleton, which is essential for controlling cell shape, movement, and the formation of cellular protrusions like filopodia. Like other Rho GTPases, Rho F functions as a molecular switch, cycling between an active, GTP-bound state and an inactive, GDP-bound state. Rho F is particularly involved in the reorganization of the cytoskeleton, facilitating processes such as actin polymerization and the formation of filopodia-slender, finger-like projections from the cell membrane that are important for sensing the extracellular environment and guiding cell movement. Inhibitors of Rho F typically function by preventing the activation or downstream signaling of this GTPase, thereby disrupting the normal cytoskeletal processes that Rho F controls.
The inhibition of Rho F can significantly affect cellular behaviors, especially those involving motility and morphological changes. By blocking Rho F activity, these inhibitors interfere with the cell's ability to form filopodia and reorganize the actin cytoskeleton, which can lead to changes in cell migration, adhesion, and interactions with the surrounding environment. Researchers use Rho F inhibitors to explore the specific contributions of this GTPase to cytoskeletal dynamics and how it regulates cellular responses to mechanical and chemical signals. These inhibitors provide valuable insights into the broader Rho GTPase family and the distinct roles that individual members, like Rho F, play in coordinating cytoskeletal architecture. Additionally, Rho F inhibitors offer a tool for investigating the molecular mechanisms that control cell shape and motility, helping to reveal how cells dynamically reorganize their cytoskeleton in response to various signals. By studying these inhibitors, scientists can deepen their understanding of the complex regulatory networks that govern cellular movement, structure, and adaptation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A selective inhibitor of ROCK (Rho-associated protein kinase), Y-27632 could indirectly influence RhoF by modulating downstream signaling pathways associated with Rho GTPases. | ||||||
CCG-1423 | 285986-88-1 | sc-205241 sc-205241A | 1 mg 5 mg | $30.00 $90.00 | 8 | |
Targets RhoA-mediated signaling and could potentially impact RhoF activity by influencing pathways shared among Rho family GTPases. | ||||||
Rhosin | 1173671-63-0 | sc-507401 | 25 mg | $555.00 | ||
Inhibits RhoA by preventing its activation. While specifically targeting RhoA, Rhosin might have an indirect effect on RhoF through shared signaling pathways or compensatory mechanisms within the cell. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $153.00 $520.00 | 4 | |
A Cdc42 inhibitor. Given the interplay between various Rho family GTPases, inhibiting Cdc42 with ML141 might indirectly impact RhoF's activity in processes involving cytoskeletal organization and cell morphology. | ||||||
Tozasertib | 639089-54-6 | sc-358750 sc-358750A | 25 mg 50 mg | $61.00 $85.00 | 4 | |
A potent Aurora kinase inhibitor. While not directly targeting Rho GTPases, Tozasertib may indirectly affect RhoF activity through its role in cell cycle regulation and cytoskeletal dynamics. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $71.00 $260.00 $485.00 $949.00 | ||
Inhibits myosin II, impacting cell motility and contractility. Blebbistatin could indirectly influence RhoF activity by altering cytoskeletal dynamics and cellular processes where Rho GTPases play a critical role. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $315.00 $1020.00 | 5 | |
An Arp2/3 complex inhibitor, CK-666 might indirectly affect RhoF function by modifying actin cytoskeleton organization and dynamics, processes in which Rho GTPases are key regulators. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
Binds to actin monomers and prevents polymerization, potentially affecting RhoF activity indirectly by altering actin dynamics and cellular architecture. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $180.00 $299.00 | 59 | |
Stabilizes actin filaments and could indirectly influence RhoF activity by affecting cytoskeletal dynamics, a key area of regulation by Rho GTPases. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $207.00 | 8 | |
An inhibitor of formin-mediated actin assembly. Given the role of Rho GTPases in regulating actin dynamics, SMIFH2 could indirectly influence RhoF's function in actin cytoskeleton organization. | ||||||